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Update of Cochrane review of rigorous studies surprisingly finds that adding psychosocial 
therapy to opiate substitute prescribing makes no difference to retention or substance 
use – a testament to the power of the routine treatment and a blow (but not a fatal one) 
to hopes that extra therapy would aid recovery and treatment exit.
Summary Maintenance treatments with pharmacological agents which substitute for 
heroin can reduce the risks associated with use of street drugs for addicts unable to 
abstain from drug use. Methadone retains patients in treatment and reduces heroin use, 
but re-addiction remains as a substantial challenge. Opiate addicts often have psychiatric 
problems such as anxiety and depression and may not be able to cope with stress. 
Psychosocial interventions including psychiatric care, psychotherapy, counselling, and 
social work services are commonly offered as part of maintenance programmes. 
Psychological support varies from structured psychotherapies such as cognitive-
behavioural therapy and supportive-expressive therapy to behavioural interventions and 
contingency management. This review addressed whether these specific psychosocial 
interventions create any additional benefit relative to usual pharmacological maintenance 
treatment, which itself routinely includes counselling.
The reviewers sought trials which randomly allocated patients to opiate substitute 
prescribing with and without extra therapy or used some other procedure to ensure 
comparability between the sets of patients. In the event all 35 studies (involving in total 
4319 participants) randomly allocated patients either as individuals or groups. The USA 
accounted for 31 studies and one each was conducted in Germany, Malaysia, China, and 
Scotland. Most often they tested therapies from the behavioural family which generally 
assume drug dependence is a learnt behaviour which can be unlearnt, and focus on 
changing behaviours rather than for example developing insights in to why those 
behaviours might have come about.
Main findings
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Without psychosocial therapy 68 of 100 patients were retained in treatment to the end of 
the study; with therapy this rose to 70, a difference which might have occurred by 
chance. Similarly the three studies which reported retention to the end of the follow-up 
period also together found no significant difference, though here the balance was actually 
in favour of standard treatment (71 versus 64 in every 100 retained).
Eight studies documented how many patients remained abstinent from non-prescribed 
opiate-type drugs as confirmed by consecutive urine tests over at least three weeks. 
Though in favour of therapy patients (on average 12% more abstinent) this difference 
was not statistically significant so might reflect chance variations. Results were similar 
across the three studies reporting abstinence at the end of the follow-up period.
Across the three studies to have reported on these variables, there were no statistically 
significant differences in treatment session attendance or in symptoms of psychological 
problems and specifically depression.
Neither were there any statistically significant improvements in these outcomes when the 
different types of psychosocial therapies were considered separately. Of these, the most 
often evaluated were therapies from the behavioural family, across which retention and 
abstinence were virtually identical regardless of whether therapy was offered. In relation 
to retention, the same was true of contingency management studies studies in particular.
The authors' conclusions
The previous version of this review found that therapy improved both retention and 
opiate abstinence; with more studies at its disposal, this update found neither to be the 
case. Though larger and further studies with longer follow-ups and rigorous, wide-
ranging assessments may yet record benefits, as things stand the evidence does not 
indicate that adding psychosocial therapy improves the effectiveness opiate substitute 
prescribing programmes. This means that methadone maintenance treatment should be 
provided even if additional psychosocial therapies cannot be funded.
It should be however be remembered that that these therapies were compared not with 
substitute drugs only, but these plus routine counselling. The results reflect the added 
value of structured psychosocial interventions implementing specific therapies, not 
whether any kind of psychosocial intervention helps.
The results of this review contrast with those of a companion review of adding 
psychosocial therapy to 'detoxification' programmes which prescribe substitute drugs on 
a reducing schedule with a view to patients becoming entirely free of these and street 
drugs. Across these studies, adding therapy did improve retention as well as reducing 
opiate use during and after treatment. The difference between impacts in these two types 
of treatments may arise because maintenance treatments have robust effects in 
themselves and counselling is usually offered along with methadone. Possibly too, 
detoxification patients are less stable – usually a personal crisis precipitates detoxification 
– and have more issues to deal with. If psychosocial interventions help with these issues, 
it seems reasonable to expect improved outcomes.
 The results of this review will be a blow to ambitions in British national drug 
policies (England; Scotland) to make methadone maintenance in Britain more recovery-
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oriented. For an expert group convened for the UK government which addressed this 
issue, psychosocial therapies were one way to enhance the recovery potential of 
methadone treatment. The review suggests that across the entire caseload, these 
therapies do not help. That they do not extend retention may be dismissed in an era 
when the emphasis has shifted to treatment exit. However, this emphasis is softened by 
the expectation that exit will be of 'recovered' addicts no longer using street drugs; it 
seems in that respect too that structured psychosocial therapies have offered no added 
value across researched caseloads.
Methadone treatment: powerful in itself
Sometimes denigrated as 'merely' substituting one drug for another, the review's findings 
are a testament to the power of routine methadone maintenance. The impact of a legal 
supply of a more 'normalising', smoother and longer acting drug like oral methadone on 
patients, many of whom previously had to offend several times a day to sustain the roller-
coaster of repeated daily heroin injections, is in itself typically rapid and powerful. Some 
examples below.
The impact was visible in a study in Baltimore where for the first four months crisis counselling only was 
provided to randomly selected patients. Over this period they did as well as patients offered standard weekly or 
more enhanced counselling and the improvements were substantial, heroin use falling from on average virtually 
daily to two to four days a month. That kind of finding has been replicated in other studies of 'interim' 
methadone arrangements which accelerate treatment entry by for a time doing without standard counselling. 
Particularly instructive was a different kind of trial in San Francisco which randomly allocated patients to 
methadone-based detoxification, or to six months of methadone maintenance with just 15 minutes of 
counselling a month or at least two sessions a month and more if needed. What made the difference to both 
heroin use and drinking was being on methadone. Additional counselling led to no further reductions or any 
other statistically significant differences in outcomes.
In Britain too questions have been raised about the benefits of and therefore the need for regular counselling. 
Finding itself overwhelmed with referrals, a prescribing service in Scotland introduced a 'low threshold' 
methadone programme which provided counselling and other forms of help only when the client actively sought 
them. The 'chaotic' caseload was typically unemployed and recently or currently homeless and injecting several 
times a day. The effect was to widen treatment access, the impact on retained patients was beneficial, and 
many went on to the full prescribing programme or to GPs. 69 of 101 patients were retained long enough to 
complete the eight-week follow-up. They reported dramatic reductions in injecting and sharing injecting 
equipment. The proportion involved in crime fell and depression receded. Discharged patients had typically 
stayed for 4.5 months, longer than envisaged, partly because many did not want to transfer to the more 
comprehensive programme with standard counselling.
Also a testament to the power of methadone maintenance, one conclusion reached by the review was that on 
average psychosocial therapies add little or nothing to this treatment but do bolster other treatments, 
specifically those which use the same drug but on a reducing detoxification schedule. It was also one finding of 
a US study of intensive case management support for welfare applicants with substance use problems. 
Providing this helped in terms of achieving abstinence, but only among applicants not already managed in 
substitute prescribing programmes. For those who were, case management made no significant difference. 
Again it is important to remember that in the US context the methadone patients would already have been 
being counselled regularly and seeing clinic staff virtually daily.
Not an argument against counselling
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The review's findings do not however mean psychosocial support is useless. First, the 
therapies tested did not exhaust the possibilities. Second is the point made by the 
reviewers that counselling was provided to comparison patients. It can be added that 
since most studies were from the USA, they would also usually have been required to 
attend the clinic almost daily to take their methadone – more potentially therapeutic staff 
contact than many British patients experience – and that generally patients volunteered 
to be randomly allocated to therapy or not. If they did so because they did not care much 
either way, it comes perhaps as no surprise that on average they did as well with as 
without.
Evidence that counselling does help in some circumstances comes from for example a US study which for the 
first 24 weeks randomly assigned 100 patients starting methadone maintenance either to monthly counselling, 
three sessions a week, or seven sessions a week plus medical, psychiatric, employment and family therapy 
services. More support led to better drug problem, crime and health outcomes. Though it cost more, the three 
times a week option was actually more cost-effective than monthly counselling in terms of the cost of services 
actually delivered per patient abstinent from heroin and cocaine.
Psychotherapy benefits only patients who need it
For research purposes, commonly studies exclude psychologically unstable patients, the 
very ones who some US studies described below suggest might have benefited from 
psychotherapy.
These studies found extra benefits from psychotherapy for methadone patients with psychiatric problems but 
not for those without. Benefits were apparent in some ways (but not in substance use) among patients with 
moderately severe problems, but more clear cut for the high severity patients who consistently improved more 
after being randomly allocated to professional psychotherapy, including a greater reduction in days of opiate 
use. Without psychotherapy, among these patients opiate use remained virtually unchanged. Clinical records 
showed that the two groups of patients with appreciable (mid or high) psychiatric severity had more drug 
positive urines when offered drug counselling alone without psychotherapy and had required higher doses of 
methadone, typically a response to continuing problems.
Later the study was broadly replicated among patients selected for severe psychiatric symptoms attending three 
more typical methadone programmes. In all 123 were sufficiently severe to be randomly allocated to an extra 
therapy session a week for 24 weeks of either supportive expressive psychotherapy, or drug counselling of the 
kind they were already receiving. On nearly every measure, by the final follow-up psychotherapy patients were 
doing better than those given drug counselling, though usually the differences were modest. After the initial 
impacts of being on methadone had evened out, patients given psychotherapy evidenced somewhat better 
psychiatric adjustment and a move towards a more conventional and law-abiding lifestyle. However, in some 
respects the effects were not as substantial as in the previous study and were not seen at the initial follow-up, 
perhaps partly because both groups of patients were offered an extra therapy session a week. This was 
intended to eliminate concerns that the earlier findings might have reflected the amount of therapeutic contact 
rather than its type. Given the relative findings of the two studies, it seems these concerns were at least partly 
valid – that perhaps amount was an important active ingredient.
But is it the therapy or the quality of the interaction?
These studies cast some doubt over the implicit assumption tested by the review that it is 
the structured, theory-driven nature of psychosocial therapy which is important. An 
alternative is that it is instead the quality and quantity of therapeutic contact with staff 
whether or not this features 'brand name' therapies. If this is what counts most, it makes 
sense that offering a little extra therapy to what is already intensive staff contact would 
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make no difference. The answer is probably a mix of both but perhaps more weighted to 
the quality of the interaction whether or not it adopts a specific therapeutic programme 
or philosophy.
This seemed the message of a rare British study which found that offering cognitive-behavioural therapy to 
methadone patients in addition to routine keyworking led to reductions in the severity of addiction and heroin 
use, and improved compliance with prescribed methadone. But with a small sample, the differences were not 
statistically significant so may have occurred by chance. If they were real it was generally not because cognitive-
behavioural therapy led to the intended psychological changes any more effectively than routine treatment. The 
findings suggest that extra therapeutic contact did help stabilise patients who were prepared to accept it, but 
whether this needed to be cognitive-behavioural or a recognised therapy of any kind seems questionable, 
particularly since in addiction treatment in general, cognitive-behavioural therapy is no more effective than 
other similarly extensive and coherent approaches, even when these amount simply to well-structured medical 
care.
As described in these Findings notes, the quality of counselling seemed decisive at a US methadone clinic where 
patients were allocated in a virtually random fashion to four drug counsellors. Two were moderately effective, 
the third very effective and the fourth not effective at all. The most effective counsellor was able to bring his 
clients to a point over a six-month period where their drug use and unemployment were significantly reduced 
when compared with the prior six months, while at the same time reducing their use of both methadone and 
ancillary psychoactive medications. By contrast, the clients of the least effective counsellor showed increased 
unemployment, drug use and criminal activity, and needed more methadone and ancillary medication. When 
the case notes were examined in detail, it became clear that the most effective counsellor was able to help 
clients anticipate their problems and assist them in developing ways of dealing with them before they arose. 
This was the quality which most clearly distinguished this counsellor from the moderately effective ones who 
were similarly qualified.
Other issues
In respect of contingency management, the review's findings differ from those of another synthesis of the 
research published in the year 2000. It found 30 relevant studies across which the systematic application of 
incentives led to more drug-free urine tests. Though effects were significantly smaller than in non-randomised 
trials, this was also the case among the 17 trials which randomly allocated patients, but effects were modest 
and even more so when urine tests were conducted less than three times a week.
According to the featured review, only 1 of 27 studies in itself found a statistically significant improvement in 
retention at the end of the study. In fact it was even worse – a remarkable clean sweep with no finding in 
favour. The one apparently positive finding seems to have been a mistake by the reviewers and that study too 
found no significant difference.
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